Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: A phase I feasibility study (Q51673640)
Jump to navigation
Jump to search
scientific article published on June 1, 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: A phase I feasibility study |
scientific article published on June 1, 2003 |
Statements
Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: A phase I feasibility study (English)
1 reference
Hans Kollberg
1 reference
David Carlander
1 reference
Hanne Olesen
1 reference
Per-Erik Wejåker
1 reference
Marie Johannesson
1 reference
Anders Larsson
1 reference
1 June 2003
1 reference
1 reference
35
1 reference
6
1 reference
433-440
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference